ArticleJournal of managed care & specialty pharmacy2021

Costs associated with the administration of erythropoiesis-stimulating agents for the treatment of anemia in patients with non-dialysis-dependent chronic kidney disease: a US societal perspective.

Marjolaine Gauthier-Loiselle et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.